Skip to content

VF BIOSCIENCE

Active
Private limited companyfounded 201511 yrs activeWaaglaan 61, 1050 Elsene, BelgiumKBO/BCE: BE 0636.963.762

The computed 12-month bankruptcy probability of VF BIOSCIENCE is 1.9% (moderate). The 2025 annual accounts show equity of €503k and a net result of €126k. Equity is growing by ~32.6% per year across the filed fiscal years. Its solvency ranks better than 40% of 1522 sector peers (fiscal year 2025). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
68 / 100
Healthy▼ -15 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency33▼-40
Growth78=
Stability100
Bankruptcy probability, 12 months
1.9% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity tight (current ratio 1.16 against 2.02 in 2024), and 78.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 10
Relative position
BE, all sectors
reference
Sector 10
higher
← fewer bankruptcies more bankruptcies →
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
21.8%
Return on assets
5.5%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 29-01-2026, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
2 d early
2024
5 d early
2023
1 d early
2022
7 d early
2021
5 d early
2020
128 d early
2019
45 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close15-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€503k▲ 5.6%
2024 · €476k
2019: €47k 2020: €103k 2021: €241k 2022: €84k 2023: €327k 2024: €476k
2019 → 2025
Total assets
€2.31M▲ 55.8%
2024 · €1.48M
2019: €181k 2020: €780k 2021: €852k 2022: €1.05M 2023: €1.31M 2024: €1.48M
2019 → 2025
Net result
€126k▼ 15.3%
2024 · €149k
2019: €30k 2020: €56k 2021: €218k 2022: €-157k 2023: €243k 2024: €149k
2019 → 2025
Working capital
€226k▼ 56.0%
2024 · €513k
2019: €44k 2020: €94k 2021: €427k 2022: €120k 2023: €419k 2024: €513k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€241k-€84k▼ 65.0%€327k▲ 289%€476k▲ 45.6%€503k▲ 5.6%
Operating result€307k-€-146k€283k€220k▼ 22.0%€183k▼ 16.8%
Net result€218k-€-157k€243k€149k▼ 38.6%€126k▼ 15.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-200k€0€200k€400kOperating result 2021: €307k€307kNet result 2021: €218k€218kOperating result 2022: €-146k€-146kNet result 2022: €-157k€-157kOperating result 2023: €283k€283kNet result 2023: €243k€243kOperating result 2024: €220k€220kNet result 2024: €149k€149kOperating result 2025: €183k€183kNet result 2025: €126k€126k20212022202320242025
The operating result has fallen two years in a row; 2025 is 17% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.31M
Fixed assets €707k▲ 52.2%
Current assets €1.60M▲ 57.5%
Equity and liabilities €2.31M
Equity €503k▲ 5.6%
Debt €1.81M▲ 79.7%
The debt ratio rises from 67.9% to 78.2%: debt grows faster than equity.
Key figures and ratios
2025 value · change against 2024
EBITDA
€240k
2024 · €264k
Cash flow
€183k
2024 · €193k
Solvency
21.8%
2024 · 32.1%
Current ratio
1.16
2024 · 2.02
Quick ratio
1.07
2024 · 2.00
Debt / equity
3.59
2024 · 2.11
ROE
25.2%
2024 · 31.3%
ROA
5.5%
2024 · 10.1%
Interest coverage
9.18
2024 · 12.52
Debt
€1.81M
2024 · €1.01M
Debt ≤ 1 year
€1.38M
2024 · €504k
Debt > 1 year
€429k
2024 · €501k
Income taxes
€39k
2024 · €51k
Staff costs
€29k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.48M€2.31M
Fixed assets21/28€464k€707k
Tangible fixed assets22/27€463k€705k
Land and buildings22€252k€240k
Plant, machinery and equipment23€18k€23k
Furniture and vehicles24€36k€40k
Other tangible fixed assets26€158k€403k
Financial fixed assets28€2k€2k=
Current assets29/58€1.02M€1.60M
Stocks and contracts in progress3€8k€127k
Stocks30/36€8k€127k
Amounts receivable within one year40/41€734k€1.28M
Trade receivables40€538k€643k
Other amounts receivable41€196k€633k
Current investments50/53€831-
Cash at bank and in hand54/58€207k€153k
Deferred charges and accrued income490/1€67k€46k
Equity and liabilities
Total equity and liabilities10/49€1.48M€2.31M
Equity10/15€476k€503k
Contributions10/11€19k€19k=
Profit (loss) carried forward14€458k€484k
Amounts payable17/49€1.01M€1.81M
Amounts payable after more than one year17€501k€429k
Financial debts170/4€501k€429k
Amounts payable within one year42/48€504k€1.38M
Current portion of amounts payable after more than one year42€113k€114k
Trade debts44€389k€1.16M
Suppliers440/4€389k€1.16M
Taxes, remuneration and social security45-€4k
Remuneration and social security454/9-€4k
Other amounts payable47/48€3k€103k
Accrued charges and deferred income492/3€174€499
Income statement Code20242025
Non-recurring operating income76A-€911
Remuneration, social security and pensions62-€29k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€44k€56k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€5k
Other operating charges640/8€3k€2k
Non-recurring operating charges66A€2k€1k
Gross operating margin9900€269k€277k
Operating profit (loss)9901€220k€183k
Financial income75/76B€1k€8k
Recurring financial income75€1k€8k
Financial charges65/66B€21k€26k
Recurring financial charges65€21k€26k
Profit (loss) for the period before taxes9903€201k€166k
Income taxes67/77€51k€39k
Profit (loss) for the period9904€149k€126k
Profit (loss) for the period to be appropriated9905€149k€126k
Appropriation of the result
Profit (loss) to be appropriated9906€458k€584k
Profit (loss) brought forward from the previous period14P€308k€458k
Profit to be distributed694/7-€100k
Return on contributions (dividend)694-€100k

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
29-01
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial Equity above €500kEq €503k ▲5.6%
3 profitable years in a row build equity to €503k.
26-01
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
30-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial Back to profitnet €243k
Net result €243k after one loss-making year.
30-06
Financial Equity above €200kEq €327k ▲289%
Equity rises from €84k to €327k.
24-01
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial Weakest financial yearnet €-157k ▼172%
Net result drops to €-157k, the lowest in the series; recovery starts the following year.
26-01
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
30-06
Financial Equity above €200kEq €241k ▲134%
3 profitable years in a row build equity to €241k.
2020
25-09
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
30-06
Financial Equity above €100kEq €103k ▲120%
2 profitable years in a row build equity to €103k.
2019
17-12
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2018
10-12
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2017
22-12
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2016
20-12
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 2 establishment units since 2015
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Waaglaan 611050 Elsene
Ground area
3,532 m²
Building footprint
1,042 m²
Volume, LiDAR
14,523 m³
2 parcels, Brussels, Flanders · tallest building 20.9 m, ±6 floors. Linked by address, not a title deed.
2 establishment units
VF Bioscience Belgium
Waaglaan 61, 1050 ElseneManufacture of food products
since 20152.246.750.226
Jeugdsquare(LIN) 1, 3210 Lubbeek
Business consulting
since 20212.318.399.869
2 parcels
Flanders 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
24063A0044/00E000 Flanders 2,455 m² 1 · 299 m² 8.1 m · 2 fl.
21446D0182/00C006 Brussels 1,078 m² 1 · 743 m² 20.9 m · 6 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Elsene2.246.750.226
1 permission
Trader · since 25-06-2021

Legal Entity Identifier

894500FSAWVXFWXI0I62
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 87 companies in sector 10860 we hold annual accounts for 47. 27 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded11-09-2015
Fiscal year end30-06
Activities, NACEBEL
10860Manufacture of food products
46389Wholesale of other food products
10890Manufacture of food products
Sources
Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.